Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality
| dc.authorid | 0000-0002-2685-2522 | |
| dc.authorid | 0000-0001-6384-2035 | |
| dc.authorid | 0000-0002-4006-1049 | |
| dc.contributor.author | Jenkins, David J. A. | |
| dc.contributor.author | Dehghan, Mahshid | |
| dc.contributor.author | Mente, Andrew | |
| dc.contributor.author | Bangdiwala, Shrikant I. | |
| dc.contributor.author | Rangarajan, Sumathy | |
| dc.contributor.author | Srichaikul, Kristie | |
| dc.contributor.author | Mohan, Viswanathan | |
| dc.date.accessioned | 2025-05-10T19:44:33Z | |
| dc.date.issued | 2021 | |
| dc.department | İstanbul Medeniyet Üniversitesi | |
| dc.description.abstract | Background Most data regarding the association between the glycemic index and cardiovascular disease come from high-income Western populations, with little information from non-Western countries with low or middle incomes. To fill this gap, data are needed from a large, geographically diverse population. Methods This analysis includes 137,851 participants between the ages of 35 and 70 years living on five continents, with a median follow-up of 9.5 years. We used country-specific food-frequency questionnaires to determine dietary intake and estimated the glycemic index and glycemic load on the basis of the consumption of seven categories of carbohydrate foods. We calculated hazard ratios using multivariable Cox frailty models. The primary outcome was a composite of a major cardiovascular event (cardiovascular death, nonfatal myocardial infarction, stroke, and heart failure) or death from any cause. Results In the study population, 8780 deaths and 8252 major cardiovascular events occurred during the follow-up period. After performing extensive adjustments comparing the lowest and highest glycemic-index quintiles, we found that a diet with a high glycemic index was associated with an increased risk of a major cardiovascular event or death, both among participants with preexisting cardiovascular disease (hazard ratio, 1.51; 95% confidence interval [CI], 1.25 to 1.82) and among those without such disease (hazard ratio, 1.21; 95% CI, 1.11 to 1.34). Among the components of the primary outcome, a high glycemic index was also associated with an increased risk of death from cardiovascular causes. The results with respect to glycemic load were similar to the findings regarding the glycemic index among the participants with cardiovascular disease at baseline, but the association was not significant among those without preexisting cardiovascular disease. Conclusions In this study, a diet with a high glycemic index was associated with an increased risk of cardiovascular disease and death. (Funded by the Population Health Research Institute and others.) In this large, international study, investigators found that participants with a broad range of carbohydrate intakes and diverse dietary patterns who consumed a diet with a high glycemic index had an increased risk of cardiovascular disease and death. | |
| dc.description.sponsorship | Population Health Research Institute; Hamilton Health Sciences Research Institute; Canadian Institutes of Health Research; Heart and Stroke Foundation of Ontario; Strategy for Patient Oriented Research of the Canadian Institutes of Health Research through the Ontario Strategy for Patient-Oriented Research Support Unit; Ontario Ministry of Health and Long-Term Care; AstraZeneca (Canada); Sanofi-Aventis (France); Sanofi-Aventis (Canada); Boehringer Ingelheim (Germany); Boehringer Ingelheim (Canada); Servier; GlaxoSmithKline; Novartis; King Pharma; Argentina: Fundacion Estudios Clinicos Latino America; Bangladesh: Independent University, Bangladesh; Bangladesh: Mitra and Associates; Brazil: Unilever Health Institute; Canada: Dairy Farmers of Canada; Canada: National Dairy Council of the United States; Canada: Public Health Agency of Canada; Canada: Champlain Cardiovascular Disease Prevention Network; Chile: Universidad de La Frontera; China: National Center for Cardiovascular Diseases; China: ThinkTank Research Center for Health Development; Colombia: Colciencias; India: Indian Council of Medical Research; Malaysia: Ministry of Science, Technology, and Innovation of Malaysia; Malaysia: Ministry of Higher Education of Malaysia; Malaysia: Universiti Teknologi MARA; Malaysia: Universiti Kebangsaan Malaysia; Palestinian territory: United Nations Relief and Works Agency for Palestine Refugees in the Near East; Philippines: Philippine Council for Health Research and Development; Poland: Polish Ministry of Science and Higher Education; Poland: Wroclaw Medical University; Saudi Arabia: Saudi Heart Association; Saudi Arabia: Dr. Mohammad Alfagih Hospital; Saudi Arabia: Deanship of Scientific Research at King Saud University; Saudi Arabia: Saleh Hamza Serafi Chair for Research of Coronary Heart Disease; Saudi Arabia: Umm al-Qura University; South Africa: North-West University; South Africa: Netherlands Programme for Alternative Development; South Africa: National Research Foundation; South Africa: Medical Research Council of South Africa; South Africa: South Africa Sugar Association; South Africa: Faculty of Community and Health Sciences; Sweden: Swedish government; Sweden: Swedish Heart and Lung Foundation; Sweden: Swedish Research Council; Sweden: Swedish Council for Health, Working Life, and Welfare; Sweden: King Gustaf V and Queen Victoria's Foundation of Freemasons; Sweden: AFA Insurance; Turkey: Metabolic Syndrome Society; Turkey: AstraZeneca; Turkey: SanofiAventis; United Arab Emirates: Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences; United Arab Emirates: Dubai Health Authority; Canada Research Chair endowment of the federal government of Canada; Marion W. Burke Chair in Cardiovascular Disease of the Heart and Stroke Foundation of Ontario; Palestinian territory: International Development Research Centre, Canada | |
| dc.description.sponsorship | Supported by the Population Health Research Institute, Hamilton Health Sciences Research Institute, the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, Strategy for Patient Oriented Research of the Canadian Institutes of Health Research through the Ontario Strategy for Patient-Oriented Research Support Unit, and the Ontario Ministry of Health and Long-Term Care; by unrestricted grants from several pharmaceutical companies, with major contributions from AstraZeneca (Canada), Sanofi-Aventis (France and Canada), Boehringer Ingelheim (Germany and Canada), Servier, and GlaxoSmithKline; and by additional contributions from Novartis and King Pharma and from various national or local organizations in participating countries as follows: Argentina: Fundacion Estudios Clinicos Latino America; Bangladesh: Independent University, Bangladesh, and Mitra and Associates; Brazil: Unilever Health Institute; Canada: Dairy Farmers of Canada, National Dairy Council of the United States, Public Health Agency of Canada, and Champlain Cardiovascular Disease Prevention Network; Chile: Universidad de La Frontera; China: National Center for Cardiovascular Diseases and ThinkTank Research Center for Health Development; Colombia: Colciencias; India: Indian Council of Medical Research; Malaysia: Ministry of Science, Technology, and Innovation of Malaysia, Ministry of Higher Education of Malaysia, Universiti Teknologi MARA, and Universiti Kebangsaan Malaysia; Palestinian territory: United Nations Relief and Works Agency for Palestine Refugees in the Near East and International Development Research Centre, Canada; Philippines: Philippine Council for Health Research and Development; Poland: Polish Ministry of Science and Higher Education and Wroclaw Medical University; Saudi Arabia: Saudi Heart Association, Dr. Mohammad Alfagih Hospital, Deanship of Scientific Research at King Saud University, Saleh Hamza Serafi Chair for Research of Coronary Heart Disease, and Umm al-Qura University; South Africa: North-West University, Netherlands Programme for Alternative Development, National Research Foundation, Medical Research Council of South Africa, South Africa Sugar Association, and Faculty of Community and Health Sciences; Sweden: Swedish government, Swedish Heart and Lung Foundation, Swedish Research Council, Swedish Council for Health, Working Life, and Welfare, King Gustaf V and Queen Victoria's Foundation of Freemasons, and AFA Insurance; Turkey: Metabolic Syndrome Society, AstraZeneca, and SanofiAventis; and the United Arab Emirates: Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences and Dubai Health Authority. Dr. Jenkins receives salary support and discretionary funding from the Canada Research Chair endowment of the federal government of Canada. Dr. S. Yusuf is supported by the Marion W. Burke Chair in Cardiovascular Disease of the Heart and Stroke Foundation of Ontario. | |
| dc.identifier.doi | 10.1056/NEJMoa2007123 | |
| dc.identifier.endpage | 1322 | |
| dc.identifier.issn | 0028-4793 | |
| dc.identifier.issn | 1533-4406 | |
| dc.identifier.issue | 14 | |
| dc.identifier.scopus | 2-s2.0-85103737739 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | 1312 | |
| dc.identifier.uri | https://doi.org/10.1056/NEJMoa2007123 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14730/10973 | |
| dc.identifier.volume | 384 | |
| dc.identifier.wos | WOS:000637799800009 | |
| dc.identifier.wosquality | Q1 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.language.iso | en | |
| dc.publisher | Massachusetts Medical Soc | |
| dc.relation.ispartof | New England Journal of Medicine | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.snmz | KA_WOS_20250302 | |
| dc.subject | Carbohydrate Intake | |
| dc.subject | Heart-Disease | |
| dc.subject | Dietary Fiber | |
| dc.subject | 18 Countries | |
| dc.subject | High-Income | |
| dc.subject | Risk | |
| dc.subject | Middle | |
| dc.subject | Pure | |
| dc.subject | Community | |
| dc.title | Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality | |
| dc.type | Article |
Dosyalar
Orijinal paket
1 - 1 / 1










